|  | 
| Mechanism30S subunit inhibitors [+2]  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.China | 
| First Approval Date23 Sep 2010 | 
100 Clinical Results associated with Neochem Pharmaceutical Laboratories Ltd.
0  Patents (Medical) associated with Neochem Pharmaceutical Laboratories Ltd.
100 Deals associated with Neochem Pharmaceutical Laboratories Ltd.
100 Translational Medicine associated with Neochem Pharmaceutical Laboratories Ltd.